首页> 美国卫生研究院文献>Annals of Surgery >Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience.
【2h】

Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience.

机译:暴发性肝炎的辅助原位肝移植。保罗·布鲁斯的经历。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

OBJECTIVE: The authors objective is to report their experience with auxiliary partial orthotopic liver transplantation in fulminant hepatitis (FH) and to discuss the principles that may help in its safe application. SUMMARY BACKGROUND DATA: Auxiliary partial orthotopic liver transplantation is an attractive therapeutic method in FH because it provides hepatic function, whereas the remaining native liver is given the possibility to recover. Despite early encouraging reports, its place in the treatment of FH remains to be defined. METHODS: Evaluation of 5 cases of FH treated with auxiliary partial orthotopic liver transplantation from a collective of 22 transplantations for 35 cases of FH referred to the authors' center from January 1994 to November 1995. The grafts were one left lobe, two left livers, and two right livers. RESULTS: The native liver regenerated in three patients: one with Reye's syndrome who died of irreversible neurologic damage, one with FH caused by the hepatitis B virus who is alive 20 months after ABO incompatible graft removal, and one with FH caused by the hepatitis A virus who had her graft removed at 4 months. In two patients, regeneration did not occur: one with drug-induced FH who died of sepsis 3 months after surgery and one with FH of unknown origin who was retransplanted with a standard liver transplantation at 4 months for uncontrollable biliary rejection of an ABO incompatible graft (alive at 10 months). Two of the three patients who survived suffered severe neurologic complications. CONCLUSIONS: Auxiliary partial orthotopic liver transplantation is an attractive treatment for FH, especially in the presence of good prognostic factors for native liver regeneration: a young patient, rapid onset of the disease, and viral hepatitis. It should be considered cautiously in patients with advanced encephalopathy. By providing a smaller mass of liver tissue than with standard orthotopic liver transplantation, and as a more complex operative procedure, auxiliary partial orthotopic liver transplantation may not be as effective in arresting the progression of neurologic damage.
机译:目的:作者的目的是报告他们在暴发性肝炎(FH)中进行辅助部分原位肝移植的经验,并讨论可能有助于其安全应用的原则。摘要背景资料:辅助部分原位肝移植是FH的一种有吸引力的治疗方法,因为它提供了肝功能,而剩余的天然肝脏则有恢复的可能性。尽管早期有令人鼓舞的报道,但其在FH治疗中的地位仍有待确定。方法:从1994年1月至1995年11月向作者中心转诊的22例移植手术中,对35例FH进行了5例FH辅助部分原位肝移植治疗。移植物为一个左叶,两个左肝,和两个右肝。结果:3例患者的天然肝脏再生:1例因不可逆的神经系统损害而死亡的Reye综合征,1例因ABO移植物不相容移植后存活20个月而死的由B型肝炎病毒引起的FH,以及1例由A型肝炎引起的FH在4个月时切除了她的嫁接病毒。在两名患者中,未发生再生:一名因药物引起的FH在手术后3个月死于败血症,另一名因来源不明的FH在4个月因无法控制的ABO不相容性胆道排斥而被标准肝移植再次移植(在10个月时生效)。幸存的三名患者中有两名患有严重的神经系统并发症。结论:辅助部分原位肝移植是FH的一种有吸引力的治疗方法,尤其是在存在天然肝再生的良好预后因素的情况下:年轻患者,疾病的快速发作和病毒性肝炎。晚期脑病患者应谨慎考虑。与标准的原位肝移植相比,通过提供较小的肝脏组织质量,并且作为更复杂的手术程序,辅助部分原位肝移植可能无法有效地阻止神经系统损伤的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号